These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9279347)

  • 1. [Efficacy of chemotherapy for clear cell adenocarcinoma of the ovary].
    Okubo T; Takeda S; Ikeba K; Takagi Y; Ishihara O; Seki H; Kinoshita K
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1279-83. PubMed ID: 9279347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced ovarian clear cell adenocarcinoma responding to cisplatin-cyclophosphamide and paclitaxel-carboplatin].
    Iwasaki K; Komuro Y; Masumoto N; Asaoka K; Ishitani K
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1483-6. PubMed ID: 10500539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.
    Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY
    Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of ovarian cancer with Parkinson's disease treated by combined chemotherapy with paclitaxel and carboplatin followed by surgery].
    Furukawa M; Fujiwara H; Urabe S; Egawa M; Fujitoh N; Sakashita T; Date K; Mizunoe T; Ueda K; Urabe T
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2129-32. PubMed ID: 14712777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A stage IIIc ovarian cancer case of pathological CR after combination treatment with carboplatin and cisplatin].
    Onishi Y; Maruyama H; Kume K; Hatae M
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2053-6. PubMed ID: 8085858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer.
    Adachi S; Itani Y; Ito K; Noda T; Shintani M; Saito K; Furukawa N; Tomii Y
    Oncol Rep; 2001; 8(1):27-31. PubMed ID: 11115564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of neo-JP therapy in the treatment of ovarian carcinoma].
    Matsunami K; Takagi H; Hasegawa Y
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):153-5. PubMed ID: 7826073
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of clear cell carcinoma of the ovary responding to a paclitaxel-carboplatin combination chemotherapy].
    Fujiwara K; Maehata K; Kohno I; Yoden E; Imajo Y; Mikami Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2259-62. PubMed ID: 11142173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Fountzilas G; Aravantinos G; Kalofonos C; Efstathiou H; Farmakis D; Skarlos D; Pavlidis N; Economopoulos T; Dimopoulos MA
    Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of poorly differentiated ovarian serous adenocarcinoma responding favorably to etoposide and cisplatin].
    Sato Y; Nishida M; Inoue K; Arai Y; Sasaki J; Kubo T
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1847-9. PubMed ID: 8937497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy with cisplatin and etoposide for cerebellar metastasis from ovarian adenocarcinoma].
    Itoyama Y; Seto H; Kochi M; Kuratsu J; Korematsu K; Kitano I; Uemura S; Ushio Y
    No Shinkei Geka; 1991 Aug; 19(8):751-4. PubMed ID: 1896120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of advanced clear cell carcinoma of the endometrium that responded remarkably to neoadjuvant chemotherapy of combination carboplatin plus weekly paclitaxel].
    Takami M; Ohta Y; Nakayama Y; Fukai H; Matsumoto H; Takimoto T; Sakamoto H; Yamamoto T
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):457-60. PubMed ID: 17353643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.
    Tung N; Berkowitz R; Matulonis U; Quartulli M; Seiden M; Kim Y; Niloff J; Cannistra SA
    Gynecol Oncol; 2000 May; 77(2):271-7. PubMed ID: 10785477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of P53 expression in selecting first-line chemotherapy regimen for advanced epithelial ovarian carcinoma].
    Zhao XD; Zhang Y; He SR; Yang L
    Ai Zheng; 2005 Dec; 24(12):1542-5. PubMed ID: 16351810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas].
    Pete I; Szánthó A; Mayer A; Thurzó L; Pulay T
    Orv Hetil; 2003 May; 144(19):919-24. PubMed ID: 12809068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment of a patient with recurrent ovarian clear cell adenocarcinoma under combination chemotherapy of 5-FU (civ) and low-dose CDDP (i.v.)].
    Sakaihara M; Sakai K; Hara Y; Kataoka S; Tabata M; Hanatani K; Hareyama H
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):127-30. PubMed ID: 10660745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.